Evidence map›Paper›PMID 40479568›Full record

ArticleAging and disease2025

Blue Zones, an Analysis of Existing Evidence through a Scoping Review.

Cristina Candal-Pedreira, Julia Rey-Brandariz, Lucía Martín-Gisbert, Ana Teijeiro, Guadalupe García, Alberto Ruano-Ravina, Mónica Pérez-Ríos

Abstract readScoping Review
In one paragraph

Article in Aging and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cristina Candal-PedreiraDepartment of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Julia Rey-BrandarizDepartment of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Lucía Martín-GisbertDepartment of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Ana TeijeiroDepartment of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Guadalupe GarcíaDepartment of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Alberto Ruano-RavinaDepartment of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Mónica Pérez-RíosDepartment of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

"Blue Zones" refer to geographical regions with a high proportion of centenarians. This review aims to identify and synthesize scientific evidence regarding Blue Zones and their characteristics. A scoping review was conducted following PRISMA-ScR guidelines. Systematic bibliographic searches were performed across major scientific databases up to February 2025. Studies were included if they investigated regions which the authors identified as Blue Zones. Non-naturally occurring Blue Zones were excluded. A narrative synthesis of the evidence was carried out. Sixty-five records were included, identifying ten regions: Ogliastra (Sardinia, Italy), Ikaria (Greece), Cilento (Italy), one municipality in The Netherlands, Menorca (Spain), Okinawa (Japan), Rugao (China), Nicoya (Costa Rica), Martinique/Guadeloupe (French overseas regions in the Caribbean) and Loma Linda (California, United States). Longevity indicators revealed that Ogliastra, Okinawa and Nicoya exhibit higher longevity compared to national averages. Ikaria and Cilento show high life expectancy, the municipality in The Netherlands show a higher proportion of exceptional longevous population than other municipalities, whereas Guadeloupe/Martinique present a higher prevalence of supercentenarian deaths than metropolitan France. Data from Menorca remain inconclusive, and Rugao has fewer centenarians. No studies have been conducted in Loma Linda. Factors associated with longevity include diet, physical activity, climate, genetic factors and geographical isolation. The literature indicates that certain geographical areas demonstrated a higher percentage of centenarians than adjacent areas. While regions such as Okinawa, Ogliastra and Nicoya are well-characterized as Blue Zones, others remain under investigation, and some currently lack sufficient scientific evidence.

Indexed as

Life ExpectancyLongevityAged, 80 and overHumans

Identifiers

PMID40479568
PMCPMC13061570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.